NAVLE Hemic and Lymphatic

Equine Infectious Anemia Study Guide

📅 March 28, 2026 ⏱ 25 min read

Overview and Clinical Importance

Equine Infectious Anemia (EIA), also known as swamp fever, is a chronic, persistent bloodborne viral disease of equids caused by the Equine Infectious Anemia Virus (EIAV), a lentivirus in the family Retroviridae. This disease is of significant veterinary importance due to its lifelong carrier state, lack of treatment or vaccine, and regulatory implications. EIA is a WOAH-notifiable disease and is reportable in all U.S. states.

The disease was first identified in France in 1843 and was one of the first animal diseases confirmed to have a viral etiology (1904). EIAV is closely related to Human Immunodeficiency Virus (HIV), making it an important model for understanding lentiviral pathogenesis and immune control.

Feature	Description
Family/Genus	Retroviridae/Lentivirus
Genome	Single-stranded RNA, approximately 8.2 kb
Virion Size	80-100 nm diameter, enveloped
Target Cells	Monocytes/macrophages (macrophage-tropic)
Key Antigens	p26 (core protein - used in Coggins test), gp45/gp90 (envelope glycoproteins)
Unique Feature	Only lentivirus lacking the vif accessory gene

Etiology

Viral Characteristics

EIAV Classification: Family Retroviridae, Genus Lentivirus. EIAV is an enveloped, single-stranded RNA virus with a genome of approximately 8.2 kb. It is the simplest of all lentiviruses, encoding only three accessory genes (tat, rev, S2) in addition to the standard retroviral genes (gag, pol, env).

High-YieldEIAV integrates its proviral DNA into the host genome using reverse transcriptase, establishing lifelong infection. Once infected, horses remain carriers for life regardless of clinical status.

Route	Mechanism	Key Points
Vector (Primary)	Mechanical transmission by blood-feeding flies	Horse flies (Tabanus spp.) and deer flies (Chrysops spp.) are most efficient; stable flies less efficient
Iatrogenic	Contaminated needles, syringes, surgical instruments, dental equipment	Most common preventable route; NEVER reuse needles between horses
Blood Products	Transfusion of infected blood or plasma	Only use blood from EIA-negative tested donors
Vertical	Transplacental or via colostrum/milk	Risk higher if mare is viremic during gestation; may cause abortion
Venereal	Via blood-contaminated semen	Rare; only if semen contains blood

Epidemiology

Global Distribution and Prevalence

EIA has a worldwide distribution and affects all members of the family Equidae including horses, ponies, donkeys, mules, and zebras. Only a few countries claim disease freedom, including Japan and Iceland. In the United States, the prevalence has decreased dramatically from approximately 4% in 1972 to approximately 0.004% currently, largely due to the implementation of the Coggins testing program.

Susceptible Species

Horses and ponies: Most commonly affected, show full range of clinical signs
Donkeys and mules: Can contract EIA but often show less severe clinical signs
Zebras: Susceptible but rarely tested
Humans: NOT susceptible - EIA is NOT zoonotic

NAVLE TipRemember that EIA is NOT zoonotic. Despite EIAV being related to HIV, there is no evidence of transmission to humans. This is a common NAVLE distractor!

Pathologic Process	Mechanism
Thrombocytopenia	Immune complex deposition on platelets leads to Fc/complement receptor-mediated clearance by splenic and hepatic macrophages
Anemia	Multifactorial: (1) Immune-mediated RBC destruction via complement, (2) Bone marrow suppression via TNF-alpha inhibition of erythropoiesis, (3) Hemolysis from viral antigen adherence to RBCs
Glomerulonephritis	Immune complex deposition (IgG + C3) on glomerular basement membrane; present in approximately 75% of chronically infected horses
Hepatomegaly/Splenomegaly	Reticuloendothelial hyperplasia; hemosiderin accumulation in Kupffer cells and splenic macrophages from RBC destruction
Edema	Immune complex-mediated vasculitis and hypoalbuminemia from hepatic dysfunction
Antigenic Variation	Viral quasispecies emerge through random mutations, evading host immunity and causing recurrent febrile episodes

Transmission

EIA is primarily a bloodborne infection. Transmission requires transfer of blood containing infected white blood cells from an infected horse to a susceptible horse.

Primary Transmission Routes

Vector Transmission Details

Transmission by biting flies is purely mechanical - the virus does NOT replicate in the insect. Key factors affecting transmission include:

Blood volume on mouthparts: Tabanids carry up to 10 nL of blood - larger than mosquitoes
Feeding interruption: Painful bites cause defensive behavior, interrupting feeding
Virus survival time: EIAV survives 30 minutes to 4 hours on fly mouthparts
Distance: Transmission unlikely beyond 200 meters (hence 200-yard quarantine rule)

High-YieldThe 200-yard (200-meter) quarantine distance is based on research showing that interrupted tabanid flies rarely travel farther than this distance to complete their blood meal. This is the minimum required separation for EIA-positive horses.

Phase	Clinical Signs	Key Features
ACUTE (1-3 days)	Fever (often greater than 104°F/40°C), depression, inappetence, thrombocytopenia	Often missed or misdiagnosed; may be mild and transient; some horses die suddenly
SUBACUTE/CHRONIC	Recurring fever, progressive anemia, weight loss, dependent edema (ventral abdomen, limbs), icterus, petechiae on mucous membranes, epistaxis, tachycardia, tachypnea	Classic "swamper" presentation; episodes recur at irregular intervals (days to months); triggered by stress or immunosuppression
INAPPARENT CARRIER	No visible clinical signs; appears healthy	MOST COMMON OUTCOME; remain seropositive and infectious for life; episodes may recur with stress/corticosteroids

Pathophysiology

Viral Replication and Immune Response

Following infection, EIAV targets and replicates primarily in tissue macrophages of the spleen, liver, lymph nodes, and bone marrow. The virus integrates into the host genome, establishing persistent, lifelong infection.

Mechanisms of Disease

NAVLE TipThe anemia in EIA is primarily IMMUNE-MEDIATED, not due to direct viral destruction of RBCs. Thrombocytopenia is often the earliest and most consistent hematologic abnormality, appearing within 3-4 days post-infection.

Test	Description	Notes
AGID (Coggins Test)	Agar Gel Immunodiffusion; detects antibodies against p26 core antigen; serum placed in wells diffuses through agar - precipitin line forms if antibodies present	Gold standard; WOAH-prescribed test; highly specific (95%); 24-48 hours for results
ELISA	Enzyme-Linked Immunosorbent Assay; detects antibodies to p26 and/or gp45 antigens	More sensitive; faster (less than 1 hour); higher false-positive rate; ELISA positives must be confirmed by AGID
Western Blot	Immunoblotting for confirmation of equivocal results	Used to clarify conflicting AGID/ELISA results
PCR	Detects proviral DNA; useful for foals from infected dams and early infection	Not routine; used when serologic results are inconclusive

Clinical Signs

Clinical presentation of EIA is highly variable, depending on viral strain virulence, infective dose, and host immune response. The incubation period ranges from 15-45 days (can extend to 3 months). The disease classically progresses through three phases.

Detailed Clinical Findings

Fever: Recurrent, often greater than 104°F (40°C), corresponds with viremic episodes
Dependent edema: Ventral abdomen, thorax, prepuce/mammary gland, distal limbs
Mucous membranes: Initially hyperemic; later pale (anemia) with icterus; petechiae may be present
Weight loss: Progressive emaciation despite good appetite in chronic cases
Exercise intolerance: Due to anemia and general debilitation
Hindlimb weakness/ataxia: Reported in some chronic cases
Abortion: May occur if mare is viremic during pregnancy

High-YieldMost EIA-positive horses appear clinically NORMAL and are only detected through routine serologic testing. Owners often report they "never noticed any clinical signs." The inapparent carrier state is the most common outcome.

Supportive Measure	Notes
Rest	Minimize stress; avoid exercise during febrile episodes
Fluids	IV fluids for dehydration support
Blood transfusion	For severe anemia (use EIA-negative donor)
NSAIDs	For fever and inflammation (use cautiously)
AVOID Corticosteroids	Can trigger viral recrudescence and clinical flare-ups

Diagnosis

Definitive diagnosis of EIA requires serologic testing. Clinical signs are nonspecific and cannot definitively diagnose EIA.

Serologic Tests

Important Diagnostic Considerations

Seroconversion window: Antibodies may not be detectable until 2-3 weeks (AGID) or earlier (ELISA) after infection - potential for false negatives in early infection
Foals from positive dams: May have maternal antibodies detectable until 6 months of age; retest at 6 months; use PCR if needed
Sample requirements: Serum only; samples stable at 2-8°C for up to 28 days
Testing must be performed by USDA-approved laboratories

Clinical Pathology Findings

Thrombocytopenia: Earliest and most consistent finding
Anemia: Normocytic, normochromic; PCV may drop to less than 20%
Hypergammaglobulinemia: Polyclonal gammopathy
Decreased serum iron: With decreased transferrin saturation
Elevated liver enzymes: Due to hepatitis

NAVLE TipThe Coggins test is named after Dr. Leroy Coggins who developed the AGID test in 1972. It detects antibodies against the p26 core antigen. A positive Coggins test = lifelong infection. There are NO false positives if the test is performed correctly.

Strategy	Implementation
Annual Testing	Test all horses annually; more frequent testing for high-risk horses
Sterile Equipment	NEVER reuse needles between horses; use sterile equipment for all procedures; disinfect dental/surgical instruments between patients
Vector Control	Fly control programs; insect repellents; remove standing water; stable horses during peak fly activity
Quarantine New Arrivals	Require negative Coggins test before introduction; consider retesting if recently obtained
Blood Products	Only use blood/plasma from EIA-negative tested donors

Pathology Findings

Gross Pathology

Splenomegaly: Often marked enlargement
Hepatomegaly: With yellowish discoloration (icterus)
Lymphadenopathy: Especially abdominal lymph nodes
Petechial hemorrhages: On spleen, kidneys, and serosal surfaces
Dependent edema: Ventral body wall, limbs
Emaciation: With serous atrophy of fat in chronic cases
Pale mucous membranes: Due to anemia

Histopathology

Liver: Nonsuppurative hepatitis; Kupffer cell hyperplasia with hemosiderin accumulation; periportal lymphocytic infiltrates
Spleen: Reticuloendothelial proliferation; hemosiderin-laden macrophages
Kidney: Glomerulonephritis with immune complex deposition; mesangial cell proliferation
Bone marrow: Usually hypercellular with increased erythropoiesis; hemosiderin-laden macrophages
CNS (rare): Periventricular leukoencephalitis, meningitis, or encephalitis

Differential	Distinguishing Features
Equine Piroplasmosis	Tick-borne; anemia and icterus; hemoglobinuria common; diagnosed by PCR or serology for Theileria equi/Babesia caballi
Immune-Mediated Hemolytic Anemia	Positive Coombs test; often responds to immunosuppressive therapy; no positive Coggins
Equine Viral Arteritis	Respiratory signs; abortion; urticarial edema; diagnosed by virus isolation or serology
Purpura Hemorrhagica	Post-Streptococcus equi infection; severe subcutaneous edema; hemorrhages; elevated serum M-protein titers
Lymphoma	Progressive weight loss; lymphadenopathy; diagnosed by cytology or biopsy
Ehrlichiosis (Potomac Horse Fever)	Diarrhea common; laminitis risk; positive PCR for Neorickettsia risticii

Treatment and Prognosis

Treatment

There is NO treatment or cure for EIA. Once infected, horses remain carriers for life. Supportive care may help manage clinical episodes but does not eliminate the virus.

Prognosis

Prognosis for cure: None - infection is lifelong
Most horses: Become inapparent carriers within 12 months and live normal lifespans
Mortality: Low during acute phase; some progress to fatal chronic disease
Outcome: Euthanasia or lifelong quarantine required by regulation

High-YieldAVOID corticosteroids in EIA-positive horses! Immunosuppression can trigger recrudescence of clinical disease. Stress, concurrent illness, and corticosteroid use are common triggers for clinical flare-ups in carrier horses.

Prevention and Control

Regulatory Requirements (United States)

Reportable disease: Laboratories must report positive results to state/federal authorities within 24 hours
Testing requirements: Negative Coggins test (within 12 months) required for interstate movement, sales, exhibitions, competitions
Positive horses must be: (1) Euthanized, OR (2) Permanently quarantined at least 200 yards from other equids
Permanent identification: Positive horses must be identified by USDA brand, tattoo, or microchip
Contact tracing: All exposed horses within 200 yards must be tested

Prevention Strategies

NAVLE TipThere is NO vaccine for EIA. Control relies entirely on identification and removal/isolation of infected horses, plus prevention of iatrogenic and vector transmission. The dramatic decrease in US prevalence (4% to 0.004%) is due to the Coggins testing program implemented in 1972.

Memory Aids

"SWAMP FEVER" Mnemonic for Clinical Signs

S - Splenomegaly W - Weight loss A - Anemia M - Mucous membrane pallor/petechiae P - Pyrexia (recurring fever)

F - Fatigue/exercise intolerance E - Edema (ventral, dependent) V - Viral (lentivirus) E - Endemic worldwide R - Reportable disease

"COGGINS = CARRIER" Memory Aid

Coggins positive = Carrier for life OIEp26 antigen detection Gold standard test Gel immunodiffusion Incurable infection No vaccine Serum testing

200-Yard Rule Memory

"Two football fields" = approximately 200 yards = minimum quarantine distance for EIA-positive horses. Based on maximum distance tabanid flies will travel to complete an interrupted blood meal.

Differential Diagnosis

The nonspecific clinical signs of EIA can mimic many other equine diseases. Consider EIA in any horse with recurrent fever, anemia, or dependent edema.

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →